Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, Jan 1997, 43-48, Vol 4, No. 1
DR Lucey, LA Pinto, FR Bethke, J Rusnak, GP Melcher, FN Hashemi, AL Landay, HA Kessler, RJ Paxton, K Grabstein and GM Shearer
Interleukin 15 (IL-15) is a cytokine that shares receptor subunits and
functional activity, such as T-cell and B-cell stimulation, with IL-2. The
effect of IL-2 on immune function and human immunodeficiency virus (HIV)
viral load in HIV-infected patients is being actively studied. Thus, we
examined how IL-15 compares with IL-2 in several in vitro immunologic and
virologic assays in order to explore whether a rationale exists for
pursuing initial clinical therapeutic trials with IL-15. The effects of
IL-15 on induction of lymphokine-activated killer (LAK) cells, gamma
interferon (IFN-gamma) production from HIV-positive peripheral blood
mononuclear cells (PBMCs), and HIV production from PBMCs were studied.
Induction of LAK cells by IL-15 was found in eight of eight HIV-positive
donors. Incubation of PBMCs from some donors with IL-15 (1, 10, 50, and 100
ng/ml) induced production of IFN-gamma. The effect of IL-15 was compared
with that of IL-2 on HIV replication in PBMCs from five HIV-positive
patients and four HIV-negative donors whose PBMCs were infected in vitro
with HIV. Levels of HIV p24 antigen were moderately lower in the presence
of 10 ng of IL-15 per ml than with 10 ng of IL-2 per ml, but they were
similar for 100 and 500 ng of each cytokine per ml. In summary, IL-15 can
induce LAK cell activity in HIV-seropositive patients and can stimulate
IFN-gamma production from PBMCs of some donors. IL-15 stimulates levels of
HIV production from PBMCs which are similar to or moderately lower than
those obtained with IL-2, depending on cytokine concentration.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |